跳至主要内容
临床试验/NL-OMON34394
NL-OMON34394招募中不适用

HEALTH-2007-2.4.5-10: Understanding and combating age related muscle weakness *MYOAGE* - MYOAGE

eids Universitair Medisch Centrum0 个研究点目标入组 265 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
265

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • patients undergoing either total knee replacement or knee periarticular reconstruction (fracture repair, corrective osteotomy, capsular ligament reconstruction) that provide for an open surgery in the lateral part of distal femur; or total/partial hip replacement or proximal femur osteosynthesis.
  • healthy young: age ranges 18-30 years;
  • elderly: age 70-80 years, free living, ADL independent

排除标准

  • PHASE 1:;Exclusion:
  • patients less than 20 years
  • patients that underwent previous open surgery in parts concerned the biopsy collection
  • patients with rheumatoid diseases (RA, polymyositis, dermatomyositis etc)
  • patients that undergo insulin therapy
  • patients with haemocoagulative syndromes in which collection could cause strong bleeding
  • patients with serious neuromuscular disease (flabby and spastic paralysis of legs, myasthenia, myodystrophia
  • patients with serious hepatorenal failure
  • patients with serious infectious disease and active malignant neoplasia
  • patients with serious psychiatric disorders, chronic abuse of alcohol and drugs
  • patients that use steroidal medicines
  • patients unable to give a personal consent
  • Participating in other ongoing research projects.;PHASE 2:
  • Participating in other ongoing research projects.
  • patients unable to give a personal consent
  • walking distance 250m and less;
  • MMSE 23 and lower;
  • GDS 5 and higher;
  • institutionalized;
  • comorbidity: neurological disorders (stroke, M. Parkinson, dementia, muscle disease), metabolic diseases (insuline dependent DM), arthritis: rheumatoid arthritis, severe (pain and functional limitation) osteoarthritis (hip and knee), cancer: diagnosis and treatment of cancer within the last year, polymyalgia rheumatic, heart failure (NYHA 3-4), COPD (Gold 3-4), chronic pain syndrome (fibromyalgia, complex regional pain syndrome etc); haemocoagulative syndromes in which biopsy could cause strong bleeding.
  • medication: immunosuppressive drugs (e.g. prednisone, methotrexat, biologicals (TNF-alpha antagonists etc)), insulin, anticoagulantia, e.g. coumarines, carbaspirin calcium.
  • fracture last year;
  • hip and knee replacement in medical history last 2 years;
  • hip and knee replacement causing pain and physical limitation;
  • amputation;
  • immobilization for 1 week during the last 3 months;
  • sports on a highly competitive level
  • severe hearing impairment.
  • severe visual impairment ..

研究者

相似试验